In honor of national Transgender Day of Remembrance, the Multicultural AIDS Coalition & Harvard University Center for AIDS Research is excited to present the debut of SHERO Talks: Virtual Journal Club Series. SHERO Talks, is a podcast series where trans women of color speak on their health,...

Robert H. Goldstein, M.D., Ph.D., and Rochelle P. Walensky, M.D., M.P.H. explain what happened with the Gilead Sciences DISCOVER trial and why it failed cisgender women and people everywhere.

From the article:
"Two months after its approval for treatment, F/TAF’s manufacturer, Gilead Sciences, moved forward with an effort to expand the drug’s indications to include prevention of HIV infection. To do so, they collaborated with researchers, community members, and the FDA to develop a new preexposure prophylaxis trial protocol — the DISCOVER trial — and to work...

September 2019 DAIDS Council-Approved Concepts

Dr. Ingrid Bassett, HU CFAR Developmental and Mentoring Core Director, was a plenary speaker at IAS 2019 in Mexico City. 

"The 10th IAS Conference on HIV Science (IAS 2019) was notable to me for two reasons. Firstly, it was a shift away from the 90-90-90 national targets to a more nuanced awareness of which populations are not being reached with existing HIV services. Secondly, differentiated service delivery (DSD) models were applied not...

"Planning for Success" NIH R-level grant writing course: an intensive online course that is open to all eligible CFAR faculty described in more detail in this website,
“Planning for Success” (PfS) is targeting CFAR faculty who:

• ...

Inter-CFAR Fellowship Program in Implementation Science for Early-Stage HIV Investigators

Collaborating CFARs: Johns Hopkins University, University of North Carolina, University of California San Francisco/GIVI, Emory University, Third Coast CFAR – Northwestern, Harvard University, University of Washington,...

The NIH-funded Centers for AIDS Research (CFARs) support research to help end the HIV epidemic in the United States, in partnership with local communities and government. A new video illustrates how the District of Columbia CFAR has contributed to decreasing new cases of HIV in the nation’s capital.

...

The HU CFAR is pleased to announce a general and special emphasis RFP for the latest cycle of Developmental Core awards to begin February 2020.  General awards may request up to $60k in direct costs.  Special emphasis awards around the topic of Community Engaged Research to Address HIV Prevention, Care and Treatment Challenges may request up to $100k in direct costs.

Take advantage of an expert pre-review to strenghten your application.  Pre-review and consultation is also available from a number of HU CFAR faculty from...

FOA was recently published on Stigma, “Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional)” https://grants.nih.gov/grants/guide/pa-files/PAR-19-326.html